S. 5022
Introduced in Senate · July 25, 2026July 16, 2026
Mr. Booker (for himself, Mr. Schumer, Mr. Wyden, Mr. Bennet, Mr. Fetterman, Mrs. Gillibrand, Mr. Hickenlooper, Mr. Luján, Mr. Padilla, Mr. Peters, Ms. Smith, Mr. Warnock, Mr. Markey, Mr. Merkley, Mrs. Murray, Ms. Warren, and Mr. Welch) introduced the following bill; which was read twice and referred to the Committee on Finance
A BILL
To decriminalize and deschedule cannabis, to provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide for expungement of certain cannabis offenses, and for other purposes.
1. Short title; table of contents; 2. Findings; 3. Definitions; TITLE I—DECRIMINALIZATION OF CANNABIS, PUBLIC SAFETY, AND STATES' RIGHTS; 101. Decriminalization of cannabis; 102. Transferring agency functions with regard to cannabis; 111. States’ rights; 112. Diversion of cannabis; TITLE II—RESEARCH, TRAINING, AND PREVENTION; 201. Societal impact of cannabis legalization study; 202. Biomedical research on cannabis; 203. Public health surveillance and data collection; 204. Awards to prevent underage cannabis use; 205. National media campaigns on cannabis use; 206. Increasing availability of cannabis products for research purposes; 207. Trans-NIH cannabis consortium; 208. Cannabis Research Interagency Advisory Committee; 209. Awards for cannabis research; 210. Department of Veterans Affairs clinical trials on the effects of cannabis on certain health outcomes of veterans with chronic pain and post-traumatic stress disorder; 211. Cannabis research infrastructure grants; 221. Definitions; 222. Cannabis-impaired driving research; 223. DOT cannabis-impaired driving prevention programs; 224. State cannabis-impaired driving prevention grant program; 225. National cannabis impairment standard; 226. Funding; TITLE III—RESTORATIVE JUSTICE AND OPPORTUNITY; 301. Opportunity trust fund programs; 302. Comprehensive opioid, stimulant, and substance use disorder program; 303. Availability of small business administration programs and services to cannabis-related legitimate businesses and service providers; 304. Demographic data of cannabis business owners and employees; 305. Pilot program; 306. Eliminating disparities among cannabis-related legitimate businesses and service providers; 311. Resentencing and expungement; 312. No discrimination in the provision of a Federal public benefit on the basis of cannabis; 313. No adverse effect for purposes of the immigration laws; 314. Provision by health care providers of the Department of Veterans Affairs of recommendations and opinions regarding veteran participation in cannabis programs; 315. Provision by health care providers of Indian health programs of recommendations and opinions regarding participation in cannabis programs; TITLE IV—TAXATION AND ESTABLISHMENT OF TRUST FUND; 401. Creation of Opportunity Trust Fund and imposition of taxes with respect to cannabis products; TITLE V—PUBLIC HEALTH, CANNABIS ADMINISTRATION, AND TRADE PRACTICES; 501. FDA regulation of cannabis; 502. Amendments to the Federal Food, Drug, and Cosmetic Act; 503. Expedited review; 504. Regulation of cannabidiol; 505. Transition periods; 506. Amendment to the Poison Prevention Packaging Act; 507. Funding for FDA; 511. Federal cannabis administration; 512. Increased funding for the Alcohol, Tobacco, and Cannabis Tax and Trade Bureau; TITLE VI—WORKPLACE HEALTH AND SAFETY PROVISIONS; 601. Definitions; 602. Finding regarding employers in the cannabis industry; 603. Cannabis as a targeted topic for Susan Harwood Training Grant Program; 604. Guidance on recommended practices; 605. Workplace impact of cannabis legalization; 606. Grants for community-based education, outreach, and enforcement with respect to the rights of workers in the cannabis industry; TITLE VII—BANKING, HOUSING, AND COMMUNITY DEVELOPMENT; 701. Purposes; sense of Congress; 702. Requirements for filing suspicious activity reports; 703. Guidance and examination procedures; 704. Investment in communities; 705. Fair access to financial services; 706. Consumer protections for individuals with nonviolent criminal record; TITLE VIII—MISCELLANEOUS; 801. Comptroller General review of laws and regulations; 802. Cannabis Products Advisory Committee; 803. Definition of hemp under USDA domestic hemp production program; 804. Grants for hiring and training relating to cannabis enforcement; 805. Severability